132 related articles for article (PubMed ID: 36681125)
1. Comprehensive characterization of complex glycosphingolipids in human pancreatic cancer tissues.
Hořejší K; Jin C; Vaňková Z; Jirásko R; Strouhal O; Melichar B; Teneberg S; Holčapek M
J Biol Chem; 2023 Mar; 299(3):102923. PubMed ID: 36681125
[TBL] [Abstract][Full Text] [Related]
2. Traveling for the glycosphingolipid path.
Hakomori S
Glycoconj J; 2000; 17(7-9):627-47. PubMed ID: 11421354
[TBL] [Abstract][Full Text] [Related]
3. Glycosphingolipid expression in human skeletal and heart muscle assessed by immunostaining thin-layer chromatography.
Müthing J; Cacić M
Glycoconj J; 1997 Jan; 14(1):19-28. PubMed ID: 9076510
[TBL] [Abstract][Full Text] [Related]
4. Glycosphingolipids of human gliomas.
Jennemann R; Rodden A; Bauer BL; Mennel HD; Wiegandt H
Cancer Res; 1990 Dec; 50(23):7444-9. PubMed ID: 2253195
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of Lewis(x) glycolipids and GD1a ganglioside in human glioma cells.
Ariga T; Bhat S; Kanda T; Yamawaki M; Tai T; Kushi Y; Kasama T; Handa S; Yu RK
Glycoconj J; 1996 Apr; 13(2):135-45. PubMed ID: 8737237
[TBL] [Abstract][Full Text] [Related]
6. A platform for the structural characterization of glycans enzymatically released from glycosphingolipids extracted from tissue and cells.
Anugraham M; Everest-Dass AV; Jacob F; Packer NH
Rapid Commun Mass Spectrom; 2015 Apr; 29(7):545-61. PubMed ID: 26212272
[TBL] [Abstract][Full Text] [Related]
7. Analysis of neutral glycosphingolipids from Trypanosoma brucei.
Uemura A; Watarai S; Kushi Y; Kasama T; Ohnishi Y; Kodama H
Vet Parasitol; 2006 Sep; 140(3-4):264-72. PubMed ID: 16806714
[TBL] [Abstract][Full Text] [Related]
8. Database and data analysis application for structural characterization of gangliosides and sulfated glycosphingolipids by negative ion mass spectrometry.
Rožman M; Fabris D; Mrla T; Vukelić Ž
Carbohydr Res; 2014 Dec; 400():1-8. PubMed ID: 25299937
[TBL] [Abstract][Full Text] [Related]
9. Isolation and structural characterization of glycosphingolipids of in vitro propagated bovine aortic endothelial cells.
Duvar S; Peter-Katalinić J; Hanisch FG; Müthing J
Glycobiology; 1997 Dec; 7(8):1099-109. PubMed ID: 9455911
[TBL] [Abstract][Full Text] [Related]
10. Application of thin-layer chromatography/infrared matrix-assisted laser desorption/ionization orthogonal time-of-flight mass spectrometry to structural analysis of bacteria-binding glycosphingolipids selected by affinity detection.
Müsken A; Souady J; Dreisewerd K; Zhang W; Distler U; Peter-Katalinić J; Miller-Podraza H; Karch H; Müthing J
Rapid Commun Mass Spectrom; 2010 Apr; 24(7):1032-8. PubMed ID: 20213676
[TBL] [Abstract][Full Text] [Related]
11. Direct analysis of silica gel extracts from immunostained glycosphingolipids by nanoelectrospray ionization quadrupole time-of-flight mass spectrometry.
Meisen I; Peter-Katalinić J; Müthing J
Anal Chem; 2004 Apr; 76(8):2248-55. PubMed ID: 15080734
[TBL] [Abstract][Full Text] [Related]
12. Glycosphingolipids of skeletal muscle: I. Subcellular distribution of neutral glycosphingolipids and gangliosides in rabbit skeletal muscle.
Müthing J; Maurer U; Neumann U; Kniep B; Weber-Schürholz S
Carbohydr Res; 1998 Feb; 307(1-2):135-45. PubMed ID: 9658569
[TBL] [Abstract][Full Text] [Related]
13. Neutral glycosphingolipid expression in B-cell neoplasms.
Kalisiak A; Minniti JG; Oosterwijk E; Old LJ; Scheinberg DA
Int J Cancer; 1991 Dec; 49(6):837-45. PubMed ID: 1959988
[TBL] [Abstract][Full Text] [Related]
14. Mass Spectrometry of Neutral Glycosphingolipids.
Suzuki A; Silsirivanit A; Watanabe T; Matsuda J; Inamori KI; Inokuchi JI
Methods Mol Biol; 2023; 2613():127-144. PubMed ID: 36587076
[TBL] [Abstract][Full Text] [Related]
15. Isolation and structural characterization of glycosphingolipids of in vitro propagated human umbilical vein endothelial cells.
Müthing J; Duvar S; Heitmann D; Hanisch FG; Neumann U; Lochnit G; Geyer R; Peter-Katalinic J
Glycobiology; 1999 May; 9(5):459-68. PubMed ID: 10207178
[TBL] [Abstract][Full Text] [Related]
16. Glycosphingolipid structural analysis and glycosphingolipidomics.
Levery SB
Methods Enzymol; 2005; 405():300-69. PubMed ID: 16413319
[TBL] [Abstract][Full Text] [Related]
17. Identification and synthetic pathway of sialyl-Lewis(x)-containing neolacto-series gangliosides in lens tissues. 2. Enzymatic synthesis of sialyl-Lewis(x) gangliosides in monkey and rat lenses.
Ogiso M; Komoto M; Hoshi M
Biochim Biophys Acta; 1996 Jan; 1315(1):29-36. PubMed ID: 8611643
[TBL] [Abstract][Full Text] [Related]
18. Characterization of moose intestinal glycosphingolipids.
Johansson MM; Dedic B; Lundholm K; Branzell FB; Barone A; Benktander J; Teneberg S
Glycoconj J; 2015 Aug; 32(6):393-412. PubMed ID: 26104834
[TBL] [Abstract][Full Text] [Related]
19. Direct analysis of sialylated or sulfated glycosphingolipids and other polar and neutral lipids using TLC-MS interfaces.
Park H; Zhou Y; Costello CE
J Lipid Res; 2014 Apr; 55(4):773-81. PubMed ID: 24482490
[TBL] [Abstract][Full Text] [Related]
20. Immunohistological analyses of neutral glycosphingolipids and gangliosides in normal mouse skeletal muscle and in mice with neuromuscular diseases.
Cacic M; Sostarić K; Weber-Schürholz S; Müthing J
Glycoconj J; 1995 Oct; 12(5):721-8. PubMed ID: 8595265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
